Insider Transactions in Q3 2021 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,096
-1.69%
|
$13,096
$1.39 P/Share
|
|
Sep 30
2021
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,484
-0.89%
|
$1,484
$1.39 P/Share
|
|
Sep 30
2021
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,480
-0.95%
|
$1,480
$1.39 P/Share
|
|
Sep 30
2021
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-0.25%
|
$206
$1.39 P/Share
|
|
Sep 02
2021
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
320,312
+29.22%
|
-
|
|
Sep 02
2021
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
BUY
Grant, award, or other acquisition
|
Direct |
60,859
+26.81%
|
-
|
|
Sep 02
2021
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
60,859
+27.99%
|
-
|
|
Sep 02
2021
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
60,859
+42.14%
|
-
|
|
Aug 25
2021
|
Patrick G Lepore Director |
BUY
Open market or private purchase
|
Direct |
12,500
+20.0%
|
$12,500
$1.6 P/Share
|
|
Aug 16
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
250,000
-4.82%
|
$250,000
$1.74 P/Share
|
|
Aug 13
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
250,000
-4.6%
|
$250,000
$1.84 P/Share
|
|
Aug 12
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
338,897
-5.87%
|
$677,794
$2.23 P/Share
|